{"falsifiability_pct":0.7468,"provenance_pct":0.9779,"trust_median":0.7,"trust_avg":0.6575907967458153,"trust_pct_below_02":0.06791823112223613,"dependency_coverage_pct":0.0,"pred_coverage":0.0,"exp_coverage":0.0,"audit_completeness_pct":1.0,"evidence_freshness_pct":1.0,"total_hypotheses":1967,"total_predictions":3729,"total_evidence":13149,"total_edges":708091,"total_experiments":29,"missing_predictions":[{"id":"h-var-787aa9d1b4","title":"Alpha-gamma cross-frequency coupling enhancement to restore thalamo-cortical memory circuits","created_at":"2026-04-12T17:20:51.833070+00:00"},{"id":"h-var-ea70ada256","title":"Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via somatostatin interneuron disinhibition in Alzheimer's disease","created_at":"2026-04-12T17:20:34.930834+00:00"},{"id":"h-var-7eaceb5a55","title":"Closed-loop focused ultrasound targeting CA1 PV interneurons to restore theta-gamma coupling and block synaptotoxic Aβ oligomers in AD","created_at":"2026-04-07T14:05:08.858766+00:00"},{"id":"h-var-6e963ed4e6","title":"Closed-loop tACS targeting EC-II somatostatin interneurons to restore dendritic integration and prevent tau-mediated HCN channel dysfunction in AD","created_at":"2026-04-20T11:46:23.713689+00:00"},{"id":"h-var-b7e4505525","title":"Closed-loop transcranial focused ultrasound targeting EC-II SST interneurons to restore hippocampal gamma oscillations via upstream perforant path gating in Alzheimer's disease","created_at":"2026-04-12T21:11:36.501434+00:00"},{"id":"h-var-e95d2d1d86","title":"Closed-loop optogenetic targeting PV interneurons to restore theta-gamma coupling and prevent amyloid-induced synaptic dysfunction in AD","created_at":"2026-04-12T21:11:44.394680+00:00"},{"id":"h-var-e81fbd3868","title":"Neutral Sphingomyelinase-2 Inhibition for Synaptic Protection in Neurodegeneration","created_at":"2026-04-07T13:53:33.865159+00:00"},{"id":"h-var-08a4d5c07a","title":"Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming in Neurodegeneration","created_at":"2026-04-05T12:38:17.110344+00:00"},{"id":"h-var-f354525002","title":"Selective Neutral Sphingomyelinase-2 Inhibition Therapy","created_at":"2026-04-12T21:12:38.953553+00:00"},{"id":"h-var-abcd9e77ce","title":"Closed-loop transcranial focused ultrasound targeting entorhinal PV interneurons to restore AnkyrinG-dependent AIS integrity and hippocampal gamma synchrony in Alzheimer's disease","created_at":"2026-04-20T11:46:14.774721+00:00"},{"id":"h-var-a0933e666d","title":"Microglial AIM2 Inflammasome as the Primary Driver of TDP-43 Proteinopathy Neuroinflammation in ALS/FTD","created_at":"2026-04-05T12:40:12.073559+00:00"},{"id":"h-var-521f97f447","title":"Closed-loop transcranial focused ultrasound with real-time gamma feedback to restore PV interneuron function in Alzheimer's disease","created_at":"2026-04-17T20:00:59.758832+00:00"},{"id":"h-var-4d43a26612","title":"Optogenetic restoration of hippocampal gamma oscillations via selective SST interneuron activation targeting dendritic inhibition in Alzheimer's disease","created_at":"2026-04-07T14:04:51.018197+00:00"},{"id":"h-var-adfecef68a","title":"Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-Synuclein Aggregates Drives Non-Cell-Autonomous Neurodegeneration","created_at":"2026-04-05T12:39:07.927708+00:00"},{"id":"h-var-9d0c0787a5","title":"APOE-TREM2 Ligand Availability Dysfunction in Neurodegeneration","created_at":"2026-04-17T20:05:35.357363+00:00"},{"id":"h-var-e53ee5ba83","title":"Optogenetic restoration of hippocampal gamma oscillations via channelrhodopsin-2 expression in PV interneurons for Alzheimer's disease treatment","created_at":"2026-04-21T12:07:20.548563+00:00"},{"id":"h-var-a4ec87f152","title":"TREM2-Senescence Cascade in Astrocyte-Microglia Communication Breakdown","created_at":"2026-04-21T12:01:33.497870+00:00"},{"id":"h-var-1a318725cd","title":"Real-time closed-loop transcranial focused ultrasound targeting PVALB interneurons with continuous gamma oscillation feedback monitoring for precision neuromodulation in Alzheimer's disease","created_at":"2026-04-21T12:07:28.696852+00:00"},{"id":"h-var-f110ef2e0a","title":"Closed-loop transcranial focused ultrasound targeting EC-II SST interneurons to prevent tau propagation and restore entorhinal-hippocampal gamma synchrony in early Alzheimer's disease","created_at":"2026-04-07T12:10:52.686629+00:00"},{"id":"h-var-223b8be521","title":"TREM2-Mediated Astroglial Reactivity in Neurodegeneration","created_at":"2026-04-21T12:01:26.764580+00:00"},{"id":"h-var-42a172bc53","title":"TREM2-Dependent Senescent Microglia Disrupt Astrocyte Communication Networks","created_at":"2026-04-21T12:07:57.962893+00:00"},{"id":"h-var-a496e5e122","title":"Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via indirect somatostatin interneuron disinhibition in Alzheimer's disease","created_at":"2026-04-20T11:46:02.966585+00:00"},{"id":"h-var-fe8899ff37","title":"TREM2-Astrocyte Communication in Microglial Dysfunction","created_at":"2026-04-21T12:07:50.080996+00:00"},{"id":"h-var-ac50d1e3d1","title":"SASP-Driven Microglial Metabolic Reprogramming in Synaptic Phagocytosis","created_at":"2026-04-07T13:53:55.931583+00:00"},{"id":"h-var-f4b4d4de63","title":"Optogenetic viral vector delivery via tFUS-mediated blood-brain barrier opening to restore hippocampal gamma oscillations through PV interneuron activation in Alzheimer's disease","created_at":"2026-04-07T13:40:53.132574+00:00"},{"id":"h-var-6c90f2e594","title":"Optogenetic restoration of hippocampal gamma oscillations via selective PV interneuron activation using implantable LED arrays in Alzheimer's disease","created_at":"2026-04-07T12:10:44.561977+00:00"},{"id":"h-var-d33964b962","title":"Real-time gamma-guided transcranial focused ultrasound targeting EC-II SST interneurons to restore hippocampal-prefrontal synchrony in early AD","created_at":"2026-04-07T13:40:38.972121+00:00"},{"id":"h-var-a4975bdd96","title":"Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via cholecystokinin interneuron neuromodulation in Alzheimer's disease","created_at":"2026-04-12T21:11:20.673313+00:00"},{"id":"h-var-d98a992599","title":"Closed-loop tACS targeting entorhinal cortex layer II SST interneurons to activate AMPK-autophagy flux and degrade intracellular tau before exosomal packaging in Alzheimer's disease","created_at":"2026-04-05T12:49:50.646064+00:00"},{"id":"h-var-862d6a66d2","title":"Closed-loop focused ultrasound targeting EC-II PV interneurons to restore theta-gamma coupling and prevent tau seeding in AD","created_at":"2026-04-07T13:40:25.482033+00:00"},{"id":"h-var-d04a952932","title":"Mitochondrial DNA-Driven AIM2 Inflammasome Activation in Neurodegeneration","created_at":"2026-04-05T12:39:07.914495+00:00"},{"id":"h-var-76afa28dfc","title":"Senescent Cell ASM-Complement Cascade Intervention","created_at":"2026-04-07T13:53:46.356507+00:00"},{"id":"h-var-9e8fc8fd3d","title":"Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via glymphatic enhancement and amyloid clearance from PV interneurons in Alzheimer's disease","created_at":"2026-04-16T19:56:42.028614+00:00"},{"id":"h-var-d749cd28cb","title":"Closed-loop transcranial alternating current stimulation to restore hippocampal-prefrontal gamma synchrony via PV interneuron rescue","created_at":"2026-04-05T12:47:54.193157+00:00"},{"id":"h-var-9da3ee8550","title":"Closed-loop tACS targeting EC-II PV interneurons to enhance perisomatic inhibition and block tau propagation in AD","created_at":"2026-04-07T12:11:00.623727+00:00"},{"id":"h-var-dce97ca507","title":"Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via glymphatic-mediated amyloid clearance and secondary PV interneuron disinhibition in Alzheimer's disease","created_at":"2026-04-17T20:00:51.477540+00:00"},{"id":"h-var-a8c6c6ea92","title":"TREM2-Mediated Mitochondrial Dysfunction in Neurodegeneration","created_at":"2026-04-20T11:42:44.808796+00:00"},{"id":"h-var-1dc420e7d8","title":"CYP46A1 Suppression for Tau-Mediated Neurodegeneration","created_at":"2026-04-07T12:14:57.884952+00:00"},{"id":"h-var-0162bdbc90","title":"Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via astrocytic calcium signaling and potassium buffering in Alzheimer's disease","created_at":"2026-04-21T11:59:47.077884+00:00"},{"id":"h-var-6957745fea","title":"Mitochondrial DAMPs-Driven AIM2 Inflammasome Activation in Neurodegeneration","created_at":"2026-04-05T12:38:17.098191+00:00"},{"id":"h-var-1647fd2642","title":"Real-time closed-loop transcranial focused ultrasound targeting PV interneurons with API-integrated biomarker validation in Alzheimer's disease","created_at":"2026-04-21T11:59:55.293061+00:00"},{"id":"h-var-3fbcfc0e6c","title":"CYP46A1 Gene Therapy for Age-Related TREM2-Mediated Microglial Senescence Reversal","created_at":"2026-04-07T12:15:05.589187+00:00"},{"id":"h-var-56a6156e67","title":"TREM2-Driven Senescence Biomarker Index for Predicting Neurodegeneration Risk","created_at":"2026-04-20T11:42:55.847326+00:00"},{"id":"h-var-af9eb8e59b","title":"Calcium-Dysregulated mPTP Opening as an Alternative mtDNA Release Mechanism for AIM2 Inflammasome Activation in Neurodegeneration","created_at":"2026-04-05T12:40:12.058744+00:00"},{"id":"h-var-ee70969116","title":"Closed-loop transcranial focused ultrasound targeting CA1 PV interneurons with real-time gamma feedback to prevent tau propagation and restore hippocampal-prefrontal synchrony in Alzheimer's disease","created_at":"2026-04-07T14:05:00.992916+00:00"}],"untraced_evidence":[{"id":"ev-2be0f0189095","claim_text":"STRING protein interaction: TYROBP-CSF1R (0.56)","source_type":"manual","created_at":"2026-04-27T23:34:46.450248+00:00"},{"id":"ev-9aee18f5387e","claim_text":"STRING protein interaction: TREM2-CSF1R (0.402)","source_type":"manual","created_at":"2026-04-27T23:34:46.450248+00:00"},{"id":"ev-7ae420ce3e68","claim_text":"APOE4 reduces TREM2 binding affinity 2-3 fold, directly impairing microglial protective functions","source_type":"manual","created_at":"2026-04-16T07:25:08+00:00"},{"id":"ev-0fbcf43e3cb5","claim_text":"TREM2 loss-of-function variants phenocopy aspects of APOE4 microglial dysfunction","source_type":"manual","created_at":"2026-04-16T07:25:08+00:00"},{"id":"ev-8185bfa59121","claim_text":"TREM2 agonist antibodies rescue APOE4-associated phagocytosis deficits in iPSC-derived microglia","source_type":"manual","created_at":"2026-04-16T07:25:08+00:00"},{"id":"ev-1602ab6afd11","claim_text":"SEA-AD single-cell data confirms TREM2 and APOE co-upregulation in DAM with disease progression","source_type":"manual","created_at":"2026-04-16T07:25:08+00:00"},{"id":"ev-2938939ffe3e","claim_text":"Combined APOE correction + TREM2 agonism shows synergistic effects in mouse models","source_type":"manual","created_at":"2026-04-16T07:25:08+00:00"},{"id":"ev-e16d9ad11f78","claim_text":"Epigenetic silencing of neuroprotective genes occurs during aging and neurodegeneration","source_type":"manual","created_at":"2026-04-16T07:25:08+00:00"},{"id":"ev-b49bafb782e1","claim_text":"CRISPRa with chromatin modifiers can reactivate silenced genes","source_type":"manual","created_at":"2026-04-16T07:25:08+00:00"},{"id":"ev-b92cfd381c22","claim_text":"Longevity genes provide protection against neurodegenerative pathology when reactivated","source_type":"manual","created_at":"2026-04-16T07:25:08+00:00"},{"id":"ev-df146e503970","claim_text":"Protein aggregation drives cell-to-cell spreading of pathology in neurodegenerative diseases","source_type":"manual","created_at":"2026-04-16T07:25:08+00:00"},{"id":"ev-d0f5386cf6b6","claim_text":"Selective elimination of severely affected neurons can prevent spread","source_type":"manual","created_at":"2026-04-16T07:25:08+00:00"},{"id":"ev-47b48ae6e50f","claim_text":"Strong interactions between LAMTOR proteins and TFEB with scores >0.8","source_type":"manual","created_at":"2026-04-16T07:25:08+00:00"},{"id":"ev-e4eb2d5db15d","claim_text":"LAMTOR complexes regulate mTOR signaling upstream of TFEB","source_type":"manual","created_at":"2026-04-16T07:25:08+00:00"},{"id":"ev-9739aed5d492","claim_text":"TFE3-TFEB interactions show high confidence scores (0.934) in protein networks","source_type":"manual","created_at":"2026-04-16T07:25:08+00:00"},{"id":"ev-1304ae4fb7f9","claim_text":"Strong YWHAG-TFEB interaction (score 0.922) suggests regulatory relationship","source_type":"manual","created_at":"2026-04-16T07:25:08+00:00"},{"id":"ev-99d2db07ee6a","claim_text":"STRING protein interaction: HDAC6-SNCA interaction confirmed (score: 0.568)","source_type":"manual","created_at":"2026-04-16T07:25:08+00:00"},{"id":"ev-ae50dc1592d2","claim_text":"GPR43/GPR41 heterodimerization detected (STRING score: 0.575)","source_type":"manual","created_at":"2026-04-16T07:25:08+00:00"},{"id":"ev-243c5b1da326","claim_text":"HDAC6 knockout mice are viable with mild phenotypes, indicating favorable safety profile for selective inhibition","source_type":"manual","created_at":"2026-04-16T07:25:08+00:00"},{"id":"ev-8dca286cfbd8","claim_text":"Crystal structures available (PDB: 5WCI, 6MRB) enabling structure-based drug design","source_type":"manual","created_at":"2026-04-16T07:25:08+00:00"},{"id":"ev-c2307e082552","claim_text":"HDAC6 shows enriched association with neurodegenerative disease (score 0.39) in Open Targets Platform","source_type":"manual","created_at":"2026-04-16T07:25:08+00:00"},{"id":"ev-85c681524d36","claim_text":"Multiple HDAC6-selective inhibitor chemotypes exist with established structure-activity relationships","source_type":"manual","created_at":"2026-04-16T07:25:08+00:00"},{"id":"ev-9d33f2dae3c7","claim_text":"APP Tau Processing pathway enriched in AD genetic risk loci (hypergeometric p=0.0041)","source_type":"manual","created_at":"2026-04-16T07:25:08+00:00"},{"id":"ev-430c90fe433d","claim_text":"OGA has established crystal structure and catalytic mechanism; multiple inhibitor chemotypes exist","source_type":"manual","created_at":"2026-04-16T07:25:08+00:00"},{"id":"ev-7cf79344c4ca","claim_text":"STRING enrichment shows AHR, FOXP3, IL10, and TIGIT co-enrich in negative regulation of immune system process (GO:0002683, FDR 9.27e-10)","source_type":"manual","created_at":"2026-04-16T07:25:08+00:00"},{"id":"ev-0aaad894f3bb","claim_text":"AHR pathway connects to BAFF-R (TNFRSF13C) signaling through receptor complex formation (GO:0043235, FDR 0.0166)","source_type":"manual","created_at":"2026-04-16T07:25:08+00:00"},{"id":"ev-fc66619cc602","claim_text":"Cross-disorder analysis showed shared vascular vulnerability patterns across dementias affecting glial-vascular interactions","source_type":"manual","created_at":"2026-04-16T07:25:08+00:00"},{"id":"ev-0ee50f9756bf","claim_text":"STRING enrichment confirms presynaptic/synaptic vesicle pathways (FDR=3.68e-06)","source_type":"manual","created_at":"2026-04-16T07:25:08+00:00"},{"id":"ev-f1d6638d5b67","claim_text":"STRING enrichment: Neuron projection terminus (p=2.45e-11), Presynapse (p=6.39e-09), Synaptic vesicle (p=6.18e-07)","source_type":"manual","created_at":"2026-04-16T07:25:08+00:00"},{"id":"ev-140d516e22e6","claim_text":"Dopaminergic synapse pathway enriched in PD gene network (hsa04728)","source_type":"manual","created_at":"2026-04-16T07:25:08+00:00"},{"id":"ev-e202a1471036","claim_text":"Endocytosis pathway enriched in AD risk loci (computational: ad_genetic_risk_loci, p=0.0003)","source_type":"manual","created_at":"2026-04-16T07:25:08+00:00"},{"id":"ev-7293326236c9","claim_text":"Trehalose is in Phase 3 ALS trial (NCT05136885)","source_type":"manual","created_at":"2026-04-16T07:25:08+00:00"},{"id":"ev-0ea0beb55a80","claim_text":"ASOs are validated modality for neurological diseases with multiple FDA approvals (nusinersen, tofersen, eteplirsen)","source_type":"manual","created_at":"2026-04-16T07:25:09+00:00"},{"id":"ev-663d8522f5e5","claim_text":"SYNGAP1 interacts with NLGN3 (STRING score: 0.405), an autism-linked synaptic adhesion molecule","source_type":"manual","created_at":"2026-04-16T07:25:09+00:00"},{"id":"ev-2ee5b097373f","claim_text":"IPA supplementation suppresses Aβ accumulation and exhibits anti-inflammatory activity in the brain","source_type":"manual","created_at":"2026-04-16T07:25:09+00:00"},{"id":"ev-e65ab9d4519e","claim_text":"STRING enrichment: MAPK signaling pathway significantly enriched in tau-associated gene network","source_type":"manual","created_at":"2026-04-16T07:25:09+00:00"},{"id":"ev-f0d53f11c201","claim_text":"GSK3B-MAP2K7 STRING interaction score 0.717 - DLK directly connects to tau kinase regulatory hub","source_type":"manual","created_at":"2026-04-16T07:25:09+00:00"},{"id":"ev-e58b1e020cd0","claim_text":"STRING interaction: DAPK1-PPP2CA score 0.457 - connects to phosphatase regulatory network","source_type":"manual","created_at":"2026-04-16T07:25:09+00:00"},{"id":"ev-cc65716b2180","claim_text":"STRING enrichment shows significant co-enrichment of GZMB and PRF1 in cytolytic granule compartment (GO:0044194, FDR=0.0059)","source_type":"manual","created_at":"2026-04-16T07:25:09+00:00"},{"id":"ev-c8bcbc157512","claim_text":"STRING enrichment shows enrichment of immune effector process pathway (GO:0002252, FDR=0.0123) connecting CXCL10-CD8A-GZMB axis","source_type":"manual","created_at":"2026-04-16T07:25:09+00:00"},{"id":"ev-09eb0602e62c","claim_text":"CXCL10 genetic variants show multiple SNP interactions (rs1869026 × rs9395969, rs9366664 × rs1600646) suggesting complex genetic regulation","source_type":"manual","created_at":"2026-04-16T07:25:09+00:00"},{"id":"ev-a2eabfe75060","claim_text":"GZMB and PRF1 co-enriched in response to virus pathway (GO:0009615, FDR=4.75e-07)","source_type":"manual","created_at":"2026-04-16T07:25:09+00:00"},{"id":"ev-7ee2ab002efb","claim_text":"STRING enrichment: Negative regulation of amyloid fibril formation (GO:1905907, FDR=0.00014) with genes APOE, CLU, TREM2","source_type":"manual","created_at":"2026-04-16T07:25:09+00:00"},{"id":"ev-e6fa39cb59e0","claim_text":"STRING enrichment: Positive regulation of amyloid fibril formation (GO:1905908, FDR=0.0016) genes: APOE, CLU","source_type":"manual","created_at":"2026-04-16T07:25:09+00:00"},{"id":"ev-2a8939e4c112","claim_text":"STRING enrichment: Reverse cholesterol transport (GO:0043691, FDR=0.0082) genes: APOE, CLU","source_type":"manual","created_at":"2026-04-16T07:25:09+00:00"},{"id":"ev-691d3d84101b","claim_text":"STRING enrichment: High-density lipoprotein particle (GOCC:0034364, FDR=0.047) genes: APOE, CLU","source_type":"manual","created_at":"2026-04-16T07:25:09+00:00"},{"id":"ev-bfb23c09bce8","claim_text":"Open Targets: TREM2 associated with late-onset Alzheimer's disease (score 0.3459) and Alzheimer's disease overall (score 0.5699)","source_type":"manual","created_at":"2026-04-16T07:25:09+00:00"},{"id":"ev-325ba7442d06","claim_text":"Glymphatic system existence and significance remain debated — some researchers argue perivascular flow is too slow for meaningful waste clearance in humans.","source_type":"manual","created_at":"2026-04-16T07:25:09+00:00"},{"id":"ev-7ee32b5e9de7","claim_text":"Orexin receptor antagonists may impair memory consolidation by disrupting REM sleep architecture, potentially counteracting clearance benefits.","source_type":"manual","created_at":"2026-04-16T07:25:09+00:00"},{"id":"ev-8f2d3fa6e454","claim_text":"AQP4 polarization to perivascular endfeet decreases with aging, potentially limiting glymphatic enhancement in elderly AD patients who would benefit most.","source_type":"manual","created_at":"2026-04-16T07:25:09+00:00"}],"low_trust_edges":[{"id":null,"source_id":"sess-hyp-af5c7b00499b","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"hyp-debate-664901bf-fd2e4946c7","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"sess_SDA-BIOMNI-BINDER_D-0657a9ed","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"hyp-debate-664901bf-4631b0c005","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"hyp-debate-664901bf-3794834b70","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"hyp-debate-664901bf-c76305721d","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"hyp-debate-664901bf-26d17faf82","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"hyp-debate-664901bf-84d6a92ee5","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"hyp-debate-664901bf-6fba5659d0","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"hyp-debate-664901bf-4e09a79389","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"sess-hyp-85e15db6a836","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"hyp-debate-664901bf-31b6e0a63b","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"hyp-debate-664901bf-05fc304fe0","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"debate-seaad-20260402","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"sess_SDA-2026-04-08-gap-debate-20260406-062033-ad87c3fb_task_9aae8fc5","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"sess_SDA-2026-04-04-gap-neuroinflammation-microglial-20260404","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"DEBATE-BIOMNI-aff2a8e1e57b","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"sess-hyp-78891e7dfa87","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"sess-gap-pubmed-20260410-150509-76c40dac-task-c747c608","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"sess_SDA-BIOMNI-SPATIAL_-c2b61633","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"sess-hyp-10e827fe5d55","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"sess_SDA-2026-04-11-gap-debate-20260410-111113-052488a8","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"sess_SDA-2026-04-04-gap-tau-prop-20260402003221","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"sess_SDA-2026-04-10-gap-debate-20260410-075000-7396040a_task_9aae8fc5","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"sess_SDA-2026-04-10-gap-pubmed-20260410-185251-10f6a211","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"sess_SDA-2026-04-11-gap-debate-20260410-105844-45a775a2","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"sess_SDA-2026-04-11-gap-debate-20260410-110223-e27ddf73","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"sess_SDA-BIOMNI-GENE_COE-55fc5237","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"sess_SDA-2026-04-04-gap-neuro-microglia-early-ad-20260404","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"sess_SDA-2026-04-04-gap-senescent-clearance-neuro","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"sess_SDA-2026-04-11-gap-debate-20260410-111536-ebde9783","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"sess_SDA-2026-04-11-gap-debate-20260410-111936-47b73d88","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"sess-hyp-ecde86af7dbe","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"sess-hyp-822bfd0cb891","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"sess_SDA-2026-04-11-gap-debate-20260410-111936-9a9b8c46","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"sess_SDA-2026-04-07-gap-pubmed-20260406-062207-e4ce5cf0_task_9aae8fc5","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"sess_SDA-2026-04-10-gap-20260410-094512","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"DEBATE-BIOMNI-18feebe39517","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"sess_SDA-2026-04-11-gap-debate-20260410-110241-04eef441","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"sess_SDA-2026-04-11-gap-debate-20260410-111943-688d4ed6","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"sess_SDA-2026-04-11-gap-debate-20260410-111928-22fc607c","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"sess_SDA-2026-04-11-gap-debate-20260410-110253-5fa88b6d","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"sess_SDA-2026-04-10-gap-debate-20260410-113045-6fcb3f6c","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"sess_SDA-2026-04-10-gap-debate-20260410-112348-a10cb6b4","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"sess-gap-pubmed-20260410-181140-0af1a353-task-c747c608","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"sess_SDA-2026-04-07-gap-debate-20260406-062052-946439a8_task_73907230","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"sess_SDA-2026-04-16-frontier-immunomics-e6f97b29","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"sess_SDA-2026-04-10-gap-debate-20260410-112625-6c2ceffa","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"sess_f7f8019f-08f6-428b-adff-85e8ea202b60_task_66f1207e_recon","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"},{"id":null,"source_id":"pan_9e2d5a81","target_id":"processed","relation":"causal_extracted","trust_score":0.0,"evidence_strength":0.0,"epistemic_status":"internal"}],"predictions_no_exp":[{"id":"pred-af4e3be8cd8b","prediction_text":"If hypothesis is true, intervention focus on dose-finding and safety in early-stage AD patients, with 24-OHC levels in cerebrospinal fluid (CSF) serving as a reliable pharmacodynamic biomarker","hypothesis_id":"h-2600483e","status":"pending"},{"id":"pred-6b8b006c10a8","prediction_text":"If hypothesis is true, intervention employ adaptive designs with CSF biomarker endpoints (Aβ42/40 ratio, phospho-tau 181/217) alongside cognitive assessments","hypothesis_id":"h-2600483e","status":"pending"},{"id":"pred-fb26c869573c","prediction_text":"If hypothesis is true, intervention deplete cholesterol below physiological levels, impairing synaptic function","hypothesis_id":"h-2600483e","status":"pending"},{"id":"pred-0e2b7f9d2f69","prediction_text":"If hypothesis is true, intervention accelerate development and reduce costs","hypothesis_id":"h-2600483e","status":"pending"},{"id":"pred-cfe0d8592ca5","prediction_text":"If hypothesis is true, intervention be durable without repeat dosing","hypothesis_id":"h-2600483e","status":"pending"},{"id":"pred-049b2be737a4","prediction_text":"If hypothesis is true, intervention become a cornerstone AD therapy, potentially applicable to other neurodegenerative diseases with circuit dysfunction (Parkinson's, frontotemporal dementia, schizophrenia)","hypothesis_id":"h-bdbd2120","status":"pending"},{"id":"pred-ecf270745586","prediction_text":"If hypothesis is true, intervention enhance sleep consolidation and duration, maximizing the natural sleep-associated glymphatic surge","hypothesis_id":"h-9e9fee95","status":"pending"},{"id":"pred-067a44f2fec1","prediction_text":"If hypothesis is true, intervention benefit from enhanced tau oligomer clearance via glymphatic pathways","hypothesis_id":"h-9e9fee95","status":"pending"},{"id":"pred-e20a2b00727c","prediction_text":"If hypothesis is true, intervention glymphatic enhancement sustained over years prevent progression? Preclinical studies show sustained benefit, but human data are limited","hypothesis_id":"h-9e9fee95","status":"pending"},{"id":"pred-13265e30b7fb","prediction_text":"If hypothesis is true, intervention be integrated into comprehensive care protocols","hypothesis_id":"h-9e9fee95","status":"pending"},{"id":"pred-d6bc2d874e61","prediction_text":"If hypothesis is true, intervention capture 10-15% as add-on to anti-amyloid/anti-tau therapies","hypothesis_id":"h-9e9fee95","status":"pending"},{"id":"pred-b559d89c9df3","prediction_text":"If hypothesis is true, intervention avoid these issues. Niemann-Pick disease provides cautionary tale: excessive ASM inhibition is toxic","hypothesis_id":"h-de0d4364","status":"pending"},{"id":"pred-41fd99d9f607","prediction_text":"If hypothesis is true, intervention establish sphingolipid metabolism as a central therapeutic axis in neurodegeneration, potentially transforming treatment paradigms across multiple diseases","hypothesis_id":"h-de0d4364","status":"pending"},{"id":"pred-c7788d4bffc6","prediction_text":"If hypothesis is true, intervention enable expansion to $50B+ metabolic disease market","hypothesis_id":"h-de0d4364","status":"pending"},{"id":"pred-aae9513d88e4","prediction_text":"If hypothesis is true, intervention enable spatial visualization of target engagement in clinical trials","hypothesis_id":"h-de0d4364","status":"pending"},{"id":"pred-92014df9f448","prediction_text":"If hypothesis is true, intervention concentrate in pathological rafts","hypothesis_id":"h-9d29bfe5","status":"pending"},{"id":"pred-116757086f91","prediction_text":"If hypothesis is true, intervention achieve differential localization","hypothesis_id":"h-9d29bfe5","status":"pending"},{"id":"pred_test_b12e2aba","prediction_text":"TREM2 knockout will increase amyloid burden by 30-50%","hypothesis_id":"hyp_test_59e50f48","status":"pending"},{"id":"pred-002ad852365e","prediction_text":"If hypothesis is true, intervention selectively inhibit ABCA1 while sparing or enhancing ABCA7","hypothesis_id":"h-9d29bfe5","status":"pending"},{"id":"pred-216edef73e7b","prediction_text":"If hypothesis is true, intervention be beneficial (enhanced synaptic cholesterol production) or detrimental (restoration of pathological raft cholesterol)","hypothesis_id":"h-9d29bfe5","status":"pending"},{"id":"pred-a7f77b08f33d","prediction_text":"If hypothesis is true, intervention translate to measurable Aβ reduction","hypothesis_id":"h-9d29bfe5","status":"pending"},{"id":"pred-63ef06582ace","prediction_text":"If hypothesis is true, intervention leverage liposomal encapsulation and targeted nanoparticle technologies to enhance compound bioavailability and cerebral penetrance","hypothesis_id":"h-e7e1f943","status":"pending"},{"id":"pred-3e9760de26dc","prediction_text":"If hypothesis is true, intervention be instrumental in comprehensively understanding the complex interactions underlying neuroinflammatory processes","hypothesis_id":"h-e7e1f943","status":"pending"},{"id":"pred-e2d26b9bf8f1","prediction_text":"GPR32 knockout in microglia","hypothesis_id":"h-959a4677","status":"pending"},{"id":"pred-b6b78abe7482","prediction_text":"Dose-response studies showing therapeutic window without receptor desensitization","hypothesis_id":"h-959a4677","status":"pending"},{"id":"pred-b798e80c9b56","prediction_text":"Comparison with direct phagocytosis enhancers (e.g., TREM2 agonists)","hypothesis_id":"h-959a4677","status":"pending"},{"id":"pred-52a2bf264fde","prediction_text":"ALOX15 overexpression in healthy astrocytes","hypothesis_id":"h-959a4677","status":"pending"},{"id":"pred-f5c92849f5e7","prediction_text":"Measure both pro- and anti-inflammatory ALOX15 products to ensure selective LXA4 production","hypothesis_id":"h-959a4677","status":"pending"},{"id":"pred-a3aad2074c90","prediction_text":"Test in ALOX15 null mice with neuroinflammation","hypothesis_id":"h-959a4677","status":"pending"},{"id":"pred-9cf55d16659d","prediction_text":"Demonstrate engineered mitochondria can actually produce SPMs in vitro","hypothesis_id":"h-959a4677","status":"pending"},{"id":"pred-f3506cd6912d","prediction_text":"Show successful delivery and integration without cellular toxicity","hypothesis_id":"h-959a4677","status":"pending"},{"id":"pred-a4aa9992628e","prediction_text":"Compare with direct SPM supplementation","hypothesis_id":"h-959a4677","status":"pending"},{"id":"pred-f3ce7c5083ed","prediction_text":"Identify and validate specific NPD1 receptors on oligodendrocytes","hypothesis_id":"h-959a4677","status":"pending"},{"id":"pred-114b9f68682f","prediction_text":"Demonstrate peptide mimetics have same effects as native NPD1","hypothesis_id":"h-959a4677","status":"pending"},{"id":"pred-fc37976e1609","prediction_text":"Test in demyelinating models with readouts for both protection and regeneration","hypothesis_id":"h-959a4677","status":"pending"},{"id":"pred-8a8a08331820","prediction_text":"Measure endogenous SPM levels in CSF during neuroinflammation","hypothesis_id":"h-959a4677","status":"pending"},{"id":"pred-c0f469cf98d4","prediction_text":"Compare shuttle system with direct CNS injection of SPMs","hypothesis_id":"h-959a4677","status":"pending"},{"id":"pred-57662feac908","prediction_text":"Assess nanocarrier-induced inflammation","hypothesis_id":"h-959a4677","status":"pending"},{"id":"pred-97ed952b0312","prediction_text":"Demonstrate ALOX12-clock protein interactions biochemically","hypothesis_id":"h-959a4677","status":"pending"},{"id":"pred-fa8460e7bc55","prediction_text":"Test in circadian knockout models","hypothesis_id":"h-959a4677","status":"pending"},{"id":"pred-b28273f9875b","prediction_text":"Compare with continuous maresin supplementation","hypothesis_id":"h-959a4677","status":"pending"},{"id":"pred-642c6666fa0c","prediction_text":"Characterize senolytic specificity in CNS cell types","hypothesis_id":"h-959a4677","status":"pending"},{"id":"pred-8455932f5f4e","prediction_text":"Test sequential vs. simultaneous combination therapy","hypothesis_id":"h-959a4677","status":"pending"},{"id":"pred-6c3f92d3ed6f","prediction_text":"Assess whether senescent microglia elimination alone is sufficient","hypothesis_id":"h-959a4677","status":"pending"},{"id":"pred-ad219721ae82","prediction_text":"If hypothesis is true, intervention achieve target CNS exposure with the standard 75/150 mg twice-daily maintenance dose","hypothesis_id":"h-0758b337","status":"pending"},{"id":"pred-d1a3c04e412d","prediction_text":"If hypothesis is true, intervention enable precision medicine approaches with individualized dosing based on real-time target engagement assessment","hypothesis_id":"h-0758b337","status":"pending"},{"id":"pred-9105179e2a92","prediction_text":"If hypothesis is true, intervention limit brain penetration","hypothesis_id":"h-0758b337","status":"pending"},{"id":"pred-20eeb6915f6e","prediction_text":"If hypothesis is true, intervention support conditional approval, with confirmatory evidence from longer-term studies required within 3-5 years post-approval","hypothesis_id":"h-0758b337","status":"pending"},{"id":"pred-6626eaac8b84","prediction_text":"If hypothesis is true, intervention prevent synapse loss while preserving beneficial immune surveillance","hypothesis_id":"h-58e4635a","status":"pending"},{"id":"pred-da04a575f013","prediction_text":"If hypothesis is true, intervention provide more precise control over BDNF expression levels and spatial distribution","hypothesis_id":"h-856feb98","status":"pending"}],"unjustified_changes":[],"stale_evidence":[],"computed_at":"2026-04-28T21:45:40.679620+00:00"}